Status:
COMPLETED
Identifying Inflammatory Biomarkers of Chronic Obstructive Pulmonary Disease
Lead Sponsor:
University of Arizona
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a condition that is characterized by airway obstruction due to inflammation. Levels of inflammatory proteins may be linked to when and to what extent CO...
Detailed Description
COPD is a term that encompasses both chronic bronchitis and emphysema, two diseases that are characterized by airway obstruction that interferes with normal breathing. Airway inflammation can stem fro...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Enrolled in the Tucson Epidemiological Study of Airway Obstructive Disease (TESAOD)
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
2085 Patients enrolled
Trial Details
Trial ID
NCT00394940
Start Date
July 1 2006
End Date
January 1 2013
Last Update
December 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arizona Respiratory Center
Tucson, Arizona, United States, 85724-5030